Amica Mutual Insurance Co. Takes Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Amica Mutual Insurance Co. bought a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the fourth quarter, HoldingsChannel reports. The fund bought 23,699 shares of the company’s stock, valued at approximately $1,451,000.

Other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter worth $25,000. Pacer Advisors Inc. raised its holdings in Prestige Consumer Healthcare by 85.7% during the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after acquiring an additional 204 shares during the period. Provence Wealth Management Group bought a new stake in Prestige Consumer Healthcare during the third quarter valued at about $26,000. ORG Partners LLC bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $36,000. Finally, International Assets Investment Management LLC raised its holdings in Prestige Consumer Healthcare by 1,900.0% during the fourth quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock valued at $60,000 after acquiring an additional 931 shares during the period. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock traded up $1.27 during trading on Monday, reaching $71.74. 124,156 shares of the stock traded hands, compared to its average volume of 236,192. The company has a market capitalization of $3.56 billion, a price-to-earnings ratio of -43.74, a P/E/G ratio of 1.91 and a beta of 0.52. The business has a fifty day simple moving average of $70.93 and a two-hundred day simple moving average of $64.27. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.09 and a quick ratio of 1.92. Prestige Consumer Healthcare Inc. has a 52-week low of $55.96 and a 52-week high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $1.04 by $0.02. The company had revenue of $282.74 million during the quarter, compared to analyst estimates of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the business posted $1.04 earnings per share. Sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on PBH shares. TheStreet raised Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 10th. One research analyst has rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $110.00.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 5,336 shares of Prestige Consumer Healthcare stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the completion of the transaction, the senior vice president now owns 15,934 shares in the company, valued at $1,099,446. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is currently owned by company insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.